Middle East & Africa Microelectrode Array In Vitro Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 106 | Report Code: BMIRE00032083 | Category: Life Sciences
No. of Pages: 106 | Report Code: BMIRE00032083 | Category: Life Sciences
The Middle East & Africa microelectrode array in vitro market was valued at US$ 0.53 million in 2023 and is expected to reach US$ 0.72 million by 2031; it is estimated to register a CAGR of 3.9% from 2023 to 2031.
Organ-on-a-chip systems are designed to replicate the physiological conditions of human organs using microfluidics and engineered tissues. When combined with microelectrode array technology, these systems can monitor electrical activity in real-time, providing insights into the functional responses of the organ models. For instance, a "heart-on-a-chip" that integrates a microelectrode array can offer data on cardiac electrophysiology, enabling researchers to evaluate the ways different compounds impact heart rhythm and contractility. This information is essential for understanding drug-induced cardiotoxicity, which poses a significant concern in pharmaceutical development. For instance, in September 2022, NETRI, a neuro-organs-on-chip start-up, partnered with Axion BioSystems to create microfluidic devices with high-throughput microelectrode arrays. This advanced technology will allow neuroscientists to noninvasively measure the electrical activity of neural cells in complex in vitro models, accelerating therapeutic discovery. The microelectrode array is crucial to the center’s organ-on-chip research, which seeks to improve biological models while reducing animal testing. The research is focused on brain-on-a-chip technology for studying neurodegenerative diseases, heart-on-a-chip technology, and blood-brain barrier modeling. Therefore, the integration of microelectrode array technologies with organ-on-a-chip devices is expected to bring new trends in the market growth in the coming years.
The microelectrode array in vitro market in the Middle East & Africa is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa. Rapid technological advancements in neuroscience and biomedical research, the presence of key players, and government initiatives to improve healthcare and research infrastructure are a few factors likely to boost the market growth in the region during the forecast period. The healthcare sector in South Africa is reforming to tackle challenges such as high incidence rates of HIV/AIDS, tuberculosis, and noncommunicable diseases (cancer and diabetes). The National Health Insurance (NHI) initiative emphasizes biotechnology and medical device innovation, including the use of microelectrode arrays in research and diagnostics. The Department of Science and Technology (DST) and the South African Medical Research Council (SAMRC) are making significant efforts to boost local production of biotechnology and medical devices, focusing on advanced tools for drug screening and disease modeling.The presence of market players such as NeuroNexus and Metrohm contributes to the expansion of the microelectrode array in vitro market in South Africa. The pharmaceutical sector in South Africa consists of both local and international companies engaged in drug discovery and development. Microelectrode arrays provide an efficient and high-throughput method for screening neurotoxicity, conducting neuropharmacology studies, and testing drug efficacy on neural cells. The increasing demand for more effective drug testing platforms is driving the adoption of microelectrode arrays in the country.
The Middle East & Africa microelectrode array in vitro market is categorized into product, application, and country.
Based on product, the Middle East & Africa microelectrode array in vitro market is divided into classical MEA, multiwell-MEA, and CMOS-MEA. The multiwell-MEA segment held the largest Middle East & Africa microelectrode array in vitro market share in 2023.
In terms of application, the Middle East & Africa microelectrode array in vitro market is segmented into cardiomyocytes, nerve, and others. The cardiomyocytes segment held the largest Middle East & Africa microelectrode array in vitro market share in 2023.
By country, the Middle East & Africa microelectrode array in vitro market is segmented into South Africa, the UAE, Saudi Arabia, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa microelectrode array in vitro market share in 2023.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 0.53 Million |
| Market Size by 2031 | US$ 0.72 Million |
| CAGR (2023 - 2031) | 3.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
|
Tucker Davis Technologies; SCREEN Holdings Co., Ltd.; Plexon Inc.; MaxWell Biosystems AG; Harvard Bioscience Inc.; Axion BioSystems Inc; 3Brain AG; NeuroNexus Technologies Inc.; MicroElectrodeDevices; Blackrock Microsystems, Inc.; NMI Technologietransfer GmbH; and BMSEED are some of the leading companies operating in the microelectrode array in vitro market.
The Middle East & Africa Microelectrode Array In Vitro Market is valued at US$ 0.53 Million in 2023, it is projected to reach US$ 0.72 Million by 2031.
As per our report Middle East & Africa Microelectrode Array In Vitro Market, the market size is valued at US$ 0.53 Million in 2023, projecting it to reach US$ 0.72 Million by 2031. This translates to a CAGR of approximately 3.9% during the forecast period.
The Middle East & Africa Microelectrode Array In Vitro Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Microelectrode Array In Vitro Market report:
The Middle East & Africa Microelectrode Array In Vitro Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Microelectrode Array In Vitro Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Microelectrode Array In Vitro Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Microelectrode Array In Vitro Market
